Barhemsys® (amisulpride) – New drug approval
February 27, 2020 - Acacia Pharma announced the FDA approval of Barhemsys (amisulpride), in adults for the prevention of postoperative nausea and vomiting (PONV), either alone or in combination with an antiemetic of a different class and for the treatment of PONV in patients who have received antiemetic prophylaxis with an agent of a different class or have not received prophylaxis.
Top